Edwin de Zwart

465 total citations
7 papers, 356 citations indexed

About

Edwin de Zwart is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Edwin de Zwart has authored 7 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Genetics. Recurrent topics in Edwin de Zwart's work include Chronic Lymphocytic Leukemia Research (3 papers), Synthesis and biological activity (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Edwin de Zwart is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Synthesis and biological activity (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Edwin de Zwart collaborates with scholars based in United States and Netherlands. Edwin de Zwart's co-authors include Tjeerd Barf, Bas van de Kar, Allard Kaptein, Bart van Lith, Michael Gulrajani, Todd Covey, Fanny Krantz, Raquel Izumi, Dennis Demont and Paul G. Pearson and has published in prestigious journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Edwin de Zwart

7 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin de Zwart United States 6 252 191 106 104 70 7 356
Bart van Lith United States 7 319 1.3× 240 1.3× 131 1.2× 105 1.0× 87 1.2× 8 406
Bas van de Kar Netherlands 8 325 1.3× 240 1.3× 129 1.2× 150 1.4× 90 1.3× 10 462
Lesley Liu‐Bujalski United States 7 192 0.8× 104 0.5× 70 0.7× 146 1.4× 98 1.4× 10 346
Fanny Krantz United States 7 401 1.6× 300 1.6× 147 1.4× 129 1.2× 128 1.8× 12 495
Jin Shu China 9 89 0.4× 86 0.5× 64 0.6× 111 1.1× 52 0.7× 18 285
Wendy B. Young United States 8 100 0.4× 44 0.2× 93 0.9× 70 0.7× 56 0.8× 13 297
Cheng Liao China 5 127 0.5× 60 0.3× 59 0.6× 75 0.7× 131 1.9× 12 268
Julie Di Paolo United States 7 190 0.8× 144 0.8× 64 0.6× 78 0.8× 76 1.1× 11 266
Kwee Hyun Suh South Korea 9 78 0.3× 48 0.3× 39 0.4× 141 1.4× 45 0.6× 32 341
Jacob LaStant United States 4 51 0.2× 42 0.2× 50 0.5× 144 1.4× 48 0.7× 4 236

Countries citing papers authored by Edwin de Zwart

Since Specialization
Citations

This map shows the geographic impact of Edwin de Zwart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin de Zwart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin de Zwart more than expected).

Fields of papers citing papers by Edwin de Zwart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin de Zwart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin de Zwart. The network helps show where Edwin de Zwart may publish in the future.

Co-authorship network of co-authors of Edwin de Zwart

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin de Zwart. A scholar is included among the top collaborators of Edwin de Zwart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin de Zwart. Edwin de Zwart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Demont, Dennis, et al.. (2021). Discovery and optimization of covalent EGFR T790M/L858R mutant inhibitors. Bioorganic & Medicinal Chemistry Letters. 52. 128406–128406. 2 indexed citations
2.
Bruin, Gerjan de, Dennis Demont, Edwin de Zwart, et al.. (2020). Discovery of quinoline-based irreversible BTK inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(14). 127261–127261. 7 indexed citations
3.
Barf, Tjeerd, Todd Covey, Raquel Izumi, et al.. (2017). Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile. Journal of Pharmacology and Experimental Therapeutics. 363(2). 240–252. 272 indexed citations
4.
Covey, Todd, Tjeerd Barf, Michael Gulrajani, et al.. (2015). Abstract 2596: ACP-196: a novel covalent Bruton's tyrosine kinase (Btk) inhibitor with improved selectivity and in vivo target coverage in chronic lymphocytic leukemia (CLL) patients. Cancer Research. 75(15_Supplement). 2596–2596. 36 indexed citations
5.
Kaptein, Allard, Arthur Oubrie, Edwin de Zwart, et al.. (2011). Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(12). 3823–3827. 17 indexed citations
6.
Oubrie, Arthur, Allard Kaptein, Edwin de Zwart, et al.. (2011). Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. Bioorganic & Medicinal Chemistry Letters. 22(1). 613–618. 13 indexed citations
7.
Adang, Anton E.P., et al.. (1999). Solution-phase and solid-phase synthesis of novel transition state inhibitors of coagulation enzymes incorporating a piperidinyl moiety. Bioorganic & Medicinal Chemistry Letters. 9(9). 1227–1232. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bart van Lith Breakdown of academic impact, for papers by Bas van de Kar Breakdown of academic impact, for papers by Lesley Liu‐Bujalski Breakdown of academic impact, for papers by Fanny Krantz Breakdown of academic impact, for papers by Jin Shu Breakdown of academic impact, for papers by Wendy B. Young Breakdown of academic impact, for papers by Cheng Liao Breakdown of academic impact, for papers by Julie Di Paolo Breakdown of academic impact, for papers by Kwee Hyun Suh Breakdown of academic impact, for papers by Jacob LaStant
Rankless by CCL
2026